Catalent (CTLT) Tops Q2 EPS by 7c

Catalent (NYSE: CTLT) reported Q2 EPS of $0.90, $0.07 better than the analyst estimate of $0.83. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.15 billion.

GUIDANCE:

Catalent sees FY2022 revenue of $4.74-4.86 billion, versus the consensus of $4.71 billion.

For earnings history and earnings-related data on Catalent (CTLT) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• HCA Healthcare cuts 2026 profit outlook on insurance exchange losses
• JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue